Breaking News Instant updates and real-time market news.

DAVE

Famous Dave's

$4.24

-0.05 (-1.17%)

, FLEX

Flex

$10.19

-0.2 (-1.92%)

18:58
08/12/19
08/12
18:58
08/12/19
18:58

Fly Intel: After Hours Movers

UP AFTER EARNINGS: Famous Dave's (DAVE) up 13.6%... FlexShopper (FLEX) up 9.6%... Bloom Energy (BE) up 6.3%... Greenlane Holdings (GNLN) up 2.7%. ALSO HIGHER: Yield10 Bioscience (YTEN) up 21.3%. DOWN AFTER EARNINGS: Victory Capital (VCTR) down 20.2%... LRAD Corp (LRAD) down 10.6%... Tencent Music (TME) down 6.5%. ALSO LOWER: Portola Pharma (PTLA) down 4.8% after equity offering... Workiva (WK) down 4.7% after equity offering. Movers as of 18:45ET.

DAVE

Famous Dave's

$4.24

-0.05 (-1.17%)

FLEX

Flex

$10.19

-0.2 (-1.92%)

BE

Bloom Energy

$8.00

-0.59 (-6.87%)

GNLN

Greenlane

$8.86

0.27 (3.14%)

YTEN

Yield10 Bioscience

$1.04

0.07 (7.22%)

VCTR

Victory Capital

$17.34

0.09 (0.52%)

LRAD

LRAD Corporation

$3.96

0.035 (0.89%)

TME

Tencent Music

$14.44

-0.01 (-0.07%)

PTLA

Portola Pharmaceuticals

$30.58

-0.42 (-1.35%)

WK

Workiva

$61.91

-1.07 (-1.70%)

  • 12

    Aug

  • 12

    Aug

  • 12

    Aug

  • 12

    Aug

  • 12

    Aug

  • 13

    Aug

  • 20

    Aug

  • 20

    Aug

  • 05

    Sep

  • 09

    Sep

  • 24

    Sep

  • 25

    Sep

  • 14

    Aug

  • 14

    Aug

DAVE Famous Dave's
$4.24

-0.05 (-1.17%)

04/03/19
MAXM
04/03/19
INITIATION
Target $9
MAXM
Buy
Famous Dave's initiated with a Buy at Maxim
Maxim analyst Stephen Anderson initiated Famous Dave's with a Buy rating and a price target of $9, saying the "turnaround story" for the company is "finally cooking". The analyst expects Famous Dave's to return to sustained comp growth and unit growth following a 26% decline in unit count since 2014 thanks to its "smaller, high-return prototype designed for off-premise sales." While he anticipates a hit to the company's operating margin from the franchised restaurant acquisition in the near term, Anderson believes that "improving restaurant-level fundamentals" will lead to a strong rebound in margins in 2020-21.
FLEX Flex
$10.19

-0.2 (-1.92%)

05/29/19
05/29/19
UPGRADE

Fly Intel: Top five analyst upgrades
Catch up on today's top five analyst upgrades with this list compiled by The Fly: 1. Flex (FLEX) upgraded to Overweight from Neutral at JPMorgan with analyst Paul Coster citing valuation. 2. Allstate (ALL) and Hartford Financial (HIG) were upgraded to Buy from Neutral at Goldman Sachs. 3. Rockwell Automation (ROK) upgraded to Buy from Hold at Gabelli with analyst Justin Bergner saying the negative investor sentiment stemming from "skepticism" of its software partnership strategy and the decline in the relevance of its programmable logic controller is unwarranted. 4. Falcon Minerals (FLMN) upgraded to Buy from Hold at Stifel with analyst Timothy Howard saying Falcon shares have underperformed over the last 30 days, falling 17% compared to peers down 6% and crude oil prices down 7%. 5. YY (YY) upgraded to Buy from Neutral at Nomura Instinet with t analyst Jialong Shi saying the risk/reward is more favorable with the stock down 27% from its recent peak. This list is just a portion of The Fly's full analyst coverage. To see The Fly's full Street Research coverage, click here.
05/29/19
JPMS
05/29/19
UPGRADE
Target $12
JPMS
Overweight
Flex upgraded to Overweight from Neutral at JPMorgan
JPMorgan analyst Paul Coster upgraded Morgan analyst Paul Coster to Overweight from Neutral with an unchanged price target of $12. The analyst cites valuation for the upgrade following the recent pullback in the shares.
06/06/19
GSCO
06/06/19
UPGRADE
Target $11
GSCO
Conviction Buy
Flex upgraded to Conviction Buy from Neutral at Goldman Sachs
Goldman Sachs analyst Mark Delaney upgraded Flex to Buy from Neutral and added the shares to his firm's Conviction Buy List with an unchanged price target of $11. The analyst had been concerned about the potential overhang from a "handful of issues," including the company's CEO search, the size of its CTG program exits and the resulting impact on earnings, and macroeconomic risk. He believes, however, that these issues now have more clarity and are priced into the stock. Delaney is also positive on the new CEO's strategy to focus on higher margins, more sustainable businesses, operational discipline, and free cash flow generation. Further, Flex shares are currently trading at a "trough" multiple, Delaney tells investors in a research note.
06/06/19
06/06/19
UPGRADE

Fly Intel: Top five analyst upgrades
Catch up on today's top five analyst upgrades with this list compiled by The Fly: 1. AMD (AMD) upgraded to Equal Weight from Underweight at Morgan Stanley with analyst Joseph Moore saying he still remains concerned that consensus forecasts for AMD in the second half of 2019 are too high, Moore acknowledges that "being cautious on the stock has obviously been the wrong call." 2. United Continental (UAL) upgraded to Buy from Neutral at Goldman Sachs with analyst Catherine O'Brien saying she sees a better risk/reward for the shares relative to Spirit Airlines (SAVE), a stock she downgraded this morning to Neutral from Buy. 3. Digital Realty (DLR) upgraded to Outperform from Market Perform at Raymond James with analyst Frank Louthan saying after he met with management, he now sees Digital Realty being poised to reverse recent underperformance compared to the group, contending that its diversified base should be a strength. 4. Outfront Media (OUT) upgraded to Outperform from In-Line at Imperial Capital with analyst David Miller saying he increased his estimates for fiscal 2019 and 2020 due the company's share gains against other forms of media. His higher estimates for 2020 are due to a "more robust" outlook for Outfront's transit business, particularly digital signage in New York City. 5. Flex (FLEX) upgraded to Conviction Buy from Neutral at Goldman Sachs with analyst Mark Delaney saying he had been concerned about the potential overhang from a "handful of issues," including the company's CEO search, the size of its CTG program exits and the resulting impact on earnings, and macroeconomic risk. He believes, however, that these issues now have more clarity and are priced into the stock. This list is just a portion of The Fly's full analyst coverage. To see The Fly's full Street Research coverage, click here.
BE Bloom Energy
$8.00

-0.59 (-6.87%)

06/20/19
BOFA
06/20/19
UPGRADE
Target $13
BOFA
Neutral
Bloom Energy upgraded to Neutral from Underperform at BofA/Merrill
BofA Merrill Lynch analyst Julien Dumoulin-Smith upgraded Bloom Energy (BE) to Neutral from Underperform as he sees shares being supported by shifting trends in its core California markets amid proactive deenergizations by PG&E (PCG) as well as more broadly across the U.S. East Coast. Following a call with Generac (GNRC) that pointed to a meaningful inflection in California customers' demand for stand-by generators, the analyst expects increased demand for Bloom's micro-grid solution, he said. He also thinks the increased focus and need for reliability with the 5G build-out for major telecom companies will support demand for Bloom products, the analyst added. He has a $13 price target on Bloom Energy shares.
03/12/19
JPMS
03/12/19
NO CHANGE
JPMS
JPMorgan likes four stocks in Alternative Energy
JPMorgan analyst Paul Coster says his Alternative Energy picks for 2019 remain Bloom Energy (BE), First Solar (FSLR), Hannon Armstrong (HASI), and TPI Composites (TPIC). The "decent" year-to-date gains notwithstanding, these four stocks offer favorable risk-reward opportunities through year-end, with Bloom and First Solar offering the highest return potential, Coster tells investors in a research note. He believes Alternative Energy fundamentals remain favorable across the spectrum of technologies, driven by "increasingly attractive unit-economics." This could be a "rare banner year for investors in Alt Energy SMid-Cap Stocks," says Coster.
03/05/19
MSCO
03/05/19
NO CHANGE
MSCO
Morgan Stanley downgrades Energy sector to Equal Weight from Overweight
Morgan Stanley equity strategist Michael Wilson said the firm's strategy team expects further declines in earnings forecasts for the Energy sector and are moving to Equal Weight from Overweight on the sector while they remain overweight Utilities. The firm's Energy and Utilities analysts highlight Baker Hughes (BHGE), Bloom Energy (BE), BP (BP), ConocoPhillips (COP), FirstEnergy (FE), Marathon Petroleum (MPC), Suncor (SU), TechnipFMC (FTI) and Tenaris (TS) as their top picks.
07/10/19
JPMS
07/10/19
NO CHANGE
JPMS
JPMorgan constructive Alternative Energy fundamentals into Q2 results
JPMorgan analyst Paul Coster remains constructive regarding Alternative Energy fundamentals into the Q2 reporting season. The analyst reiterates First Solar (FSLR), TPI Composites (TPIC), Hannon Armstrong (HASI) and Bloom Energy (BE) as his top picks. He highlights "strong" global demand, stable average selling prices, and improved clarity regarding government policy, especially in China.
GNLN Greenlane
$8.86

0.27 (3.14%)

06/20/19
COWN
06/20/19
NO CHANGE
Target $21
COWN
Outperform
Greenlane fundamentals remain intact, selloff 'overdone,' says Cowen
Cowen analyst Vivien Azer believes the selloff in Greenlane shares appears "overdone" following news of the potential e-cigarette ban in San Francisco. The analyst remains confident in the company's long-term fundamentals and believes valuation remains attractive. Azer would continue to be a buyer at current levels. She reiterates an Outperform rating and $21 price target on the shares.
05/13/19
NORL
05/13/19
INITIATION
Target $23
NORL
Outperform
Greenlane initiated with an Outperform at Northland
Northland analyst Mike Grondahl initiated Greenlane with an Outperform and $23 price target saying it is well positioned to benefit from the shift to non-combustion nicotine consumption along with growing CBD and legal cannabis markets. Grondahl said Greenlane has a strong position in the distribution network as a partner with well known vaporizer companies, combined with many other products and accessories, and a growing share of internally developed brands.
05/14/19
ROTH
05/14/19
INITIATION
Target $22.5
ROTH
Buy
Greenlane initiated with a Buy at Roth Capital
Roth Capital analyst Scott Fortune started coverage of Greenlane with a Buy rating and $22.50 price target. The analyst expects a number of growth drivers, including new strategic supplier partnerships, brand development, increased regulations in packaging, securing new cannabis operators in expanding legal states, deepening customer relationships cross-selling opportunity as the one stop-shop, e-commerce reach, and overall cannabis derivative use.
06/21/19
06/21/19
NO CHANGE

Former FDA head sees difficulty in JUUL getting PMTA approval, says Cowen
Cowen analyst Vivien Azer wrote in a note titled "Gottlieb: Out of FDA, Not Out of Opinions" that former FDA Commissioner Scott Gottlieb commented that he believes it will be difficult for JUUL to get PMTA approval, which has put vapor exposed stocks under pressure. Azer said that Altria (MO) has direct exposure as it has a 35% stake in JUUL, and Greenlane Holdings (GNLN) also has exposure as JUUL accounted for 36% of its sales in 2018. However, the analyst noted that JUUL is "already grand-fathered into the market today, given it was marketed prior to August 2016." Also, JUUL has been "among the most proactive participants in the market, having gone further than the FDA has contemplated in terms of addressing youth access." Azer has a Market Perform rating on Altria, and an Outperform rating on Greenlane.
YTEN Yield10 Bioscience
$1.04

0.07 (7.22%)

01/23/19
NATL
01/23/19
INITIATION
Target $5
NATL
Buy
Yield10 Bioscience initiated with a Buy at National Securities
National Securities initiated Yield10 Bioscience with a Buy and $5 price target.
07/22/19
AGIS
07/22/19
INITIATION
Target $2
AGIS
Buy
Yield10 Bioscience initiated with a Buy at Aegis
Aegis analyst James Jang started Yield10 Bioscience with a Buy rating and $2 price target.
VCTR Victory Capital
$17.34

0.09 (0.52%)

07/09/19
MSCO
07/09/19
NO CHANGE
MSCO
Morgan Stanley sees C-corp conversion announcement coming from Carlyle
Morgan Stanley analyst Michael Cyprys said he recommends owning Carlyle Group (CG) shares into the quarter, as he believes the company will announce plans to convert to a C-corporation along with its upcoming report, "albeit with a delayed effective date" to allow time for the complex underlying tax impact analysis. He thinks a conversion could bring greater clarity and visibility into targets, which could increase long only interest in the stock, Cyprys tells investors. In his broader preview of the earnings season for the Asset Manager group, the analyst noted that he lowered his Q2 EPS estimates by about 4% on average, cutting his estimates for Traditionals by 0.5%, for Alts by 11.5% and for Market Structure companies by 1.6%.
07/23/19
GSCO
07/23/19
UPGRADE
Target $24
GSCO
Buy
Victory Capital reinstated with a Buy from Neutral at Goldman Sachs
Goldman Sachs analyst Alexander Blostein upgraded Victory Capital Holdings to Buy from Neutral with a $24 price target after reinstating coverage of the name. Although Victory faces many of the same challenges affecting the traditional asset management industry, the stock's valuation is "unreasonably low" at a time when the company's fundamentals are starting to strengthen, Blostein tells investors in a research note. He believes the completion of the USAA Asset Management acquisition creates "considerable" earnings accretion while also diversifying the company's asset mix.
07/26/19
MSCO
07/26/19
NO CHANGE
MSCO
Schwab deal positive for E-Trade, negative for Victory, says Morgan Stanley
After Charles Schwab (SCHW) announced an agreement to acquire assets of USAA's Investment Management Company, including brokerage and managed portfolio accounts, for $1.8B in cash, Morgan Stanley analyst Michael Cyprys said he believes mid-single digit accretion is achievable with upside potential. In terms of read-across to others in the industry, he thinks the acquisition could raise prospects for greater brokerage/wealth management industry consolidation in which peers, including E-Trade (ETFC) and TD Ameritrade (AMTD), could potentially benefit, Cyprys tells investors. However, he believes Schwab's acquisition could be negative for Victory Capital (VCTR) as it introduces significant competition within the USAA membership network. Cyprys keeps an Overweight rating on Charles Schwab shares with a $48 price target.
07/02/19
RILY
07/02/19
NO CHANGE
Target $24
RILY
Buy
Victory Capital price target raised to $24 from $20 at B. Riley FBR
B. Riley FBR analyst Randy Binner raised his price target for Victory Capital to $24 from $20 and keeps a Buy rating on the shares following the close of the USAA acquisition. Victory announced that it expects 2019 earnings to grow more than 40%, with 2020 expected at more than 100%, Binner tells investors in a research note.
LRAD LRAD Corporation
$3.96

0.035 (0.89%)

07/02/19
OPCO
07/02/19
INITIATION
Target $5
OPCO
Outperform
LRAD Corporation initiated with an Outperform at Oppenheimer
Oppenheimer analyst Andrew Uerkwitz started LRAD Corporation with an Outperform rating and $5 price target. The company is a leader in long range voice broadcast systems and advanced public safety notification, Uerkwitz tells investors in a research note. The analyst believes LRAD is in the middle of a "slow, long tail global growth cycle" as communities update updating antiquate alarm notification systems. He thinks its earnings can grow "substantially faster" as the company continues to scale.
TME Tencent Music
$14.44

-0.01 (-0.07%)

07/30/19
OPCO
07/30/19
INITIATION
Target $18
OPCO
Outperform
Opco starts Tencent Music at Outperform on 'massive monetization potential'
Oppenheimer analyst Bo Pei last night initiated coverage of Tencent Music with an Outperform rating and $18 price target. The company operates four of the five most popular digital music apps in China with market penetration of over 90%, Pei tells investors in a research note. However, only 4.3% of users subscribe to Tencent's music service and 4.8% of its users pay for social entertainment, which provides "massive monetization potential," contends the analyst. He believes Tencent Music will benefit from enhanced content leadership in the long term.
07/29/19
OPCO
07/29/19
INITIATION
Target $18
OPCO
Outperform
Tencent Music initiated with an Outperform at Oppenheimer
Oppenheimer initiated Tencent Music with an Outperform and $18 price target.
08/05/19
JEFF
08/05/19
INITIATION
Target $16.9
JEFF
Buy
Tencent Music initiated with a Buy at Jefferies
Jefferies analyst Thomas Chong initiated Tencent Music with a Buy rating and $16.90 price target, stating that he expects a rising paying ratio for membership as the company transitions from a pay-for-download to a pay-for-streaming model. He also thinks its investment in self-produced content can enhance user stickiness and monetization in the longer-term, Chong noted.
07/30/19
07/30/19
INITIATION

Fly Intel: Top five analyst initiations
Catch up on today's top five analyst initiations with this list compiled by The Fly: 1. Tencent Music (TME) initiated with an Outperform at Oppenheimer. 2. Medallia (MDLA) initiated with an Overweight at Stephens. 3. Fanhua (FANH) initiated with an Overweight at Morgan Stanley. 4. Philips (PHG) initiated with a Buy at Citi. 5. Freshpet (FRPT) initiated with a Neutral at JPMorgan. This list is just a portion of The Fly's analyst coverage. To see The Fly's full Street Research coverage, click here.
PTLA Portola Pharmaceuticals
$30.58

-0.42 (-1.35%)

08/05/19
FBCO
08/05/19
INITIATION
Target $35
FBCO
Neutral
Portola Pharmaceuticals assumed with a Neutral at Credit Suisse
Credit Suisse analyst Tiago Fauth assumed coverage of Portola Pharmaceuticals with a Neutral rating and $35 price target.
07/10/19
FBCO
07/10/19
INITIATION
Target $35
FBCO
Neutral
Portola Pharmaceuticals assumed with a Neutral at Credit Suisse
Credit Suisse analyst Uy Ear assumed coverage of Portola Pharmaceuticals with a Neutral rating and $35 price target.
08/05/19
08/05/19
INITIATION

Fly Intel: Top five analyst initiations
Catch up on today's top five analyst initiations with this list compiled by The Fly: 1. Alphatec (ATEC) initiated with an Overweight at Piper Jaffray. 2. So-Young (SY) initiated with a Buy at CLSA. 3. MediWound (MDWD) initiated with a Buy at H.C. Wainwright. 4. Portola Pharmaceuticals (PTLA) assumed with a Neutral at Credit Suisse. 5. Vereit (VER) initiated with an Equal Weight at Morgan Stanley. This list is just a portion of The Fly's analyst coverage. To see The Fly's full Street Research coverage, click here.
08/08/19
SBSH
08/08/19
NO CHANGE
Target $51
SBSH
Buy
The time to buy Portola Pharmaceuticals is now, says Citi
In a post-earnings research note titled "The Time to Buy is Now," Citi analyst Yigal Nochomovitz raised his price target for Portola Pharmaceuticals to $51 from $50 and keeps a Buy rating on the shares. The analyst continues to believe Andexxa can be a ~$250M product in 2020 and ~$550M by 2022. Getting to half a billion in sales would require one use per month per hospital, assuming "only" ~1500 active hospitals, which is "very achievable," Nochomovitz tells investors in a research note. This means Portola's fair value is ~$50 per share, not the market view of $27 per share, says the analyst.
WK Workiva
$61.91

-1.07 (-1.70%)

09/25/18
BARD
09/25/18
UPGRADE
Target $42
BARD
Outperform
Workiva upgraded to Outperform at Baird
As reported previously, Baird analyst Rob Oliver upgraded Workiva to Outperform from Neutral. The analyst cited bullish checks at the company's user conference, the increased demand in its financial suite, success in expanding cases for WDesk, better sales execution, and accelerating margin expansion. Oliver raised his price target to $42 from $27 on Workiva shares.
09/26/18
RHCO
09/26/18
NO CHANGE
Target $46
RHCO
Buy
Workiva price target raised to $46 from $39 at SunTrust
SunTrust analyst Terry Tillman raised his price target on Workiva to $46 and kept his Buy rating after its user conference last week, saying the conversations with some "large customers" indicated expansion of the company's use cases and showcased its "solid value proposition of cost and time savings". The analyst notes that the event increased his confidence in the company's ability to accelerate subscription and support revenues, adding that Workiva has a number of "various catalysts in place in helping drive accelerating growth in 2019" that could render his forecasts as "conservative".
08/07/19
RHCO
08/07/19
NO CHANGE
Target $65
RHCO
Buy
Workiva price target raised to $65 from $58 at SunTrust
SunTrust analyst Terry Tillman raised his price target on Workiva to $65 and kept his Buy rating after its Q2 earnings beat and above-consensus FY19 guidance along with improved customer metrics showing the benefits of transition to a solution based pricing model, large deal activity, and strong retention rates. The analyst believes the company has multiple upside catalysts that also include international expansion and growing use-case adoption to further accelerate its revenue growth.
05/02/19
RHCO
05/02/19
NO CHANGE
Target $58
RHCO
Buy
Workiva price target raised to $58 from $50 at SunTrust
SunTrust analyst Terry Tillman raised his price target on Workiva to $58 and kept his Buy rating, saying its positive momentum accelerated in Q1 with better than expected subscription revenue and billings. The analyst expects Workiva's subscription revenue to accelerate by over 20%, supported by bigger deal activity, international opportunity, and deeper penetration with existing customers.

TODAY'S FREE FLY STORIES

CBS

CBS

$43.83

0.5 (1.15%)

, VIA

Viacom

$27.27

-0.4 (-1.45%)

08:03
08/17/19
08/17
08:03
08/17/19
08:03
Periodicals
Viacom-CBS merger got panned by investors, Barron's says »

CBS (CBS) and Viacom…

CBS

CBS

$43.83

0.5 (1.15%)

VIA

Viacom

$27.27

-0.4 (-1.45%)

VIAB

Viacom

$26.02

0.09 (0.35%)

AAPL

Apple

$206.44

4.71 (2.33%)

DIS

Disney

$135.19

1.79 (1.34%)

T

AT&T

$34.98

0.64 (1.86%)

CMCSA

Comcast

$43.17

0.82 (1.94%)

CMCSK

Comcast

$0.00

(0.00%)

NFLX

Netflix

$302.74

6.81 (2.30%)

AMZN

Amazon.com

$1,791.82

16.72 (0.94%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 05

    Sep

  • 05

    Sep

  • 23

    Sep

  • 23

    Oct

  • 27

    Oct

MYGN

Myriad Genetics

$25.36

2.14 (9.22%)

07:57
08/17/19
08/17
07:57
08/17/19
07:57
Periodicals
Myriad Genetics stock might have an FDA issue, Barron's says »

Myriad Genetics plunged…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 13

    Nov

CSCO

Cisco

$46.96

0.73 (1.58%)

, NTAP

NetApp

$46.75

0.33 (0.71%)

07:50
08/17/19
08/17
07:50
08/17/19
07:50
Periodicals
Trade war hitting tech stocks, Barron's says »

Cisco (CSCO) plunged 9% a…

CSCO

Cisco

$46.96

0.73 (1.58%)

NTAP

NetApp

$46.75

0.33 (0.71%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 09

    Sep

  • 12

    Sep

  • 10

    Oct

  • 13

    Nov

RDS.A

Royal Dutch Shell

$55.55

0.47 (0.85%)

, RDS.B

Royal Dutch Shell

$55.56

0.46 (0.83%)

07:47
08/17/19
08/17
07:47
08/17/19
07:47
Periodicals
Investors should not abandon oil, gas stocks, Barron's says »

Energy stocks have rarely…

RDS.A

Royal Dutch Shell

$55.55

0.47 (0.85%)

RDS.B

Royal Dutch Shell

$55.56

0.46 (0.83%)

BP

BP

$36.27

0.22 (0.61%)

XOM

Exxon Mobil

$68.30

1.06 (1.58%)

CVX

Chevron

$115.79

0.08 (0.07%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 27

    Aug

  • 25

    Sep

TGT

Target

$84.20

1.67 (2.02%)

, WMT

Walmart

$112.99

0.32 (0.28%)

07:40
08/17/19
08/17
07:40
08/17/19
07:40
Periodicals
Grocery Outlet thriving as rivals struggle, Barron's says »

While Dow was down 800…

TGT

Target

$84.20

1.67 (2.02%)

WMT

Walmart

$112.99

0.32 (0.28%)

GO

Grocery Outlet

$46.55

2.81 (6.42%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 21

    Aug

  • 15

    Sep

  • 19

    Sep

  • 25

    Sep

  • 13

    Nov

  • 14

    Nov

AEO

American Eagle

$15.40

0.63 (4.27%)

07:33
08/17/19
08/17
07:33
08/17/19
07:33
Periodicals
American Eagle to soar despite trade war, Barron's says »

American Eagle's…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 04

    Sep

  • 25

    Sep

ANGI

Angi Homeservices

$8.18

-0.18 (-2.15%)

, MTCH

Match Group

$84.53

2.08 (2.52%)

07:27
08/17/19
08/17
07:27
08/17/19
07:27
Periodicals
Dating business might be IAC's best asset, greatest challenge, Barron's says »

IAC (IAC) has rallied 34%…

ANGI

Angi Homeservices

$8.18

-0.18 (-2.15%)

MTCH

Match Group

$84.53

2.08 (2.52%)

IAC

IAC

$249.17

4.21 (1.72%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 05

    Sep

  • 10

    Sep

  • 10

    Oct

AAPL

Apple

$206.44

4.71 (2.33%)

, HAS

Hasbro

$114.29

1.13 (1.00%)

07:13
08/17/19
08/17
07:13
08/17/19
07:13
On The Fly
Week in review How Trump's policies moved stocks »

Catch up on the top…

AAPL

Apple

$206.44

4.71 (2.33%)

HAS

Hasbro

$114.29

1.13 (1.00%)

MAT

Mattel

$10.74

(0.00%)

AGR

Avangrid

$49.29

0.37 (0.76%)

JPM

JPMorgan

$107.73

2.52 (2.40%)

BAC

Bank of America

$27.04

0.79 (3.01%)

C

Citi

$63.46

2.13 (3.47%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 06

    Sep

  • 09

    Sep

  • 02

    Oct

  • 15

    Oct

  • 15

    Oct

  • 16

    Oct

  • 27

    Oct

NCLH

Norwegian Cruise Line

$50.48

1.38 (2.81%)

18:04
08/16/19
08/16
18:04
08/16/19
18:04
Hot Stocks
Norwegian Cruise Line CEO sells 25K shares of common stock »

In a regulatory filing,…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

RM

Regional Management

$27.12

0.14 (0.52%)

18:01
08/16/19
08/16
18:01
08/16/19
18:01
Hot Stocks
Regional Management CFO buys 5K shares of common stock »

In a regulatory filing,…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 13

    Nov

RTN

Raytheon

$178.10

-0.42 (-0.24%)

17:59
08/16/19
08/16
17:59
08/16/19
17:59
Hot Stocks
Raytheon awarded $199.59M Navy contract for MK 15 CIWS »

Raytheon has been awarded…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

WEN

Wendy's

$19.94

0.16 (0.81%)

17:57
08/16/19
08/16
17:57
08/16/19
17:57
Hot Stocks
Breaking Hot Stocks news story on Wendy's »

Trian Fund lowers…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 13

    Nov

BRY

Berry Petroleum

$8.59

0.39 (4.76%)

17:54
08/16/19
08/16
17:54
08/16/19
17:54
Syndicate
Breaking Syndicate news story on Berry Petroleum »

Berry Petroleum files to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

CSWI

CSW Industrials

$70.20

1.92 (2.81%)

17:52
08/16/19
08/16
17:52
08/16/19
17:52
Hot Stocks
CSW Industrials CEO sells 25K shares of common stock »

In a regulatory filing,…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

OAS

Oasis Petroleum

$3.03

0.135 (4.66%)

17:49
08/16/19
08/16
17:49
08/16/19
17:49
Hot Stocks
Oasis Petroleum CEO buys 30K shares of common stock »

In a regulatory filing,…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

EE

El Paso Electric

$66.41

0.005 (0.01%)

17:45
08/16/19
08/16
17:45
08/16/19
17:45
Hot Stocks
El Paso Electric director Wertheimer sells 25K shares of common stock »

In a regulatory filing,…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

HON

Honeywell

$165.07

2.81 (1.73%)

17:42
08/16/19
08/16
17:42
08/16/19
17:42
Hot Stocks
Honeywell CEO sells 7.1K shares of common stock »

In a regulatory filing,…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

MBRX

Moleculin Biotech

$1.08

0.01 (0.93%)

17:37
08/16/19
08/16
17:37
08/16/19
17:37
Earnings
Moleculin Biotech reports Q2 EPS (3c), two estimates (10c) »

CFO Jonathan Foster…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

VIVE

Viveve

$0.13

0.0046 (3.59%)

17:35
08/16/19
08/16
17:35
08/16/19
17:35
Syndicate
Breaking Syndicate news story on Viveve »

Viveve files to sell…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

PRGO

Perrigo

$46.21

0.535 (1.17%)

17:30
08/16/19
08/16
17:30
08/16/19
17:30
Hot Stocks
Breaking Hot Stocks news story on Perrigo »

Starboard lowers Perrigo…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 01

    Oct

UAL

United Continental

$82.96

1.36 (1.67%)

17:28
08/16/19
08/16
17:28
08/16/19
17:28
Hot Stocks
United Continental director Shapiro buys 10K shares of common stock »

In a regulatory filing,…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 04

    Sep

  • 05

    Sep

  • 23

    Sep

MBIO

Mustang Bio

$3.88

0.19 (5.15%)

17:26
08/16/19
08/16
17:26
08/16/19
17:26
Syndicate
Breaking Syndicate news story on Mustang Bio »

Mustang Bio files to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 04

    Sep

BCLI

BrainStorm

$3.63

0.055 (1.54%)

17:24
08/16/19
08/16
17:24
08/16/19
17:24
Syndicate
Breaking Syndicate news story on BrainStorm »

BrainStorm files to sell…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

WLK

Westlake Chemical

$61.27

0.66 (1.09%)

17:15
08/16/19
08/16
17:15
08/16/19
17:15
Hot Stocks
Westlake Chemical raises quarterly dividend by 5% to 26.25c per share »

The dividend will be…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

GIG

GigCapital

$10.30

(0.00%)

17:10
08/16/19
08/16
17:10
08/16/19
17:10
Hot Stocks
GigCapital receives noncompliance notice from NYSE »

GigCapital announced that…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.